-
Products_type
Peptide
-
Products_short_name
[BRCA1]
-
Other_names
[breast cancer type 1 susceptibility protein isoform 1; Breast cancer type 1 susceptibility protein; breast cancer type 1 susceptibility protein; breast cancer 1, early onset; RING finger protein 53]
-
Products_gene_name
[BRCA1]
-
Other_gene_names
[BRCA1; BRCA1; IRIS; PSCP; BRCAI; BRCC1; FANCS; PNCA4; RNF53; BROVCA1; PPP1R53; RNF53]
-
Form
50 ug (0.2 mg/ml) in phosphate buffered saline (PBS), pH 7.2, containing 50% glycerol, 1% BSA and 0.02% thimerosal.Appearance: Colorless liquid
-
Concentration
0.2 mg/ml
-
Storage_stability
At -20 degree CShelf Life: 12 months
-
Tested_application
Western Blot (WB)
-
Test
You can block the antibody by the specific target amino acid sequence of peptide.
-
Properties
blocking peptide
-
Description
Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
-
Gene target
-
Gene symbol
BRCA1, BRCA1P1
-
Short name
BRCA1 Blocking Peptide
-
Technique
blocking peptide, Blocking, peptide, blocking peptides, MyBioSource made this blocking amino acid sequence or peptide to block the gene target in a volume of 1. For western blot it is often requested to block your antibody and to see the band of the analyzed protein disappear. This is called a negative control by blocking the WB antibody. peptides
-
Alternative name
breast cancer 1, early onset inhibiting short protein sequence
-
Alternative technique
control, peptides
-
Alternative to gene target
breast cancer 1, early onset, BRCAI and BRCC1 and BROVCA1 and IRIS and PNCA4 and PPP1R53 and PSCP and RNF53, BRCA1 and IDBG-52172 and ENSG00000012048 and 672, androgen receptor binding, nuclei, Brca1 and IDBG-212218 and ENSMUSG00000017146 and 12189, BRCA1 and IDBG-640630 and ENSBTAG00000022520 and 353120
-